The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo

Read, C, Nyimanu, D, Yang, P et al. (7 more authors) (2021) The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo. Frontiers in Pharmacology, 11. 588669. ISSN 1663-9812

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 Read, Nyimanu, Yang, Kuc, Williams, Fitzpatrick, Foster, Glen, Maguire and Davenport. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: apelin, bias, cardiovascular, in vivo, apoptosis, pulmonary artery endothelial cell, G protein coupled receptor
Dates:
  • Accepted: 2 December 2020
  • Published (online): 21 January 2021
  • Published: 21 January 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Engineering & Physical Sciences (Leeds) > School of Chemistry (Leeds) > Organic Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 18 Jun 2021 13:36
Last Modified: 18 Jun 2021 13:36
Status: Published
Publisher: Frontiers Media
Identification Number: https://doi.org/10.3389/fphar.2020.588669

Export

Statistics